Security key
00860C102
Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share (AGMB)
CUSIP: 00860C102
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / American Depositary Shares, each representing one common share, no nominal value per share
- Total 13F shares
- 23,354,227
- Total 13F value
- $245,296,936
- Share change
- +23,354,227
- SEC-reported price per share
- $10.49
- Number of holders
- 32
- Value change
- +$245,296,936
- Number of buys
- 32
- Shares outstanding
- 49,208,543
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
32
Top holders
10
AGMB full security history
Ownership snapshot
Full 13F holder table
Agomab Therapeutics NV SEC filings
Agomab Therapeutics NV company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00860C102
Recent filing periods:
Ownership snapshot
Top reported holders of AGMB - Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
7. Cooperative Ua Lsp
Disclosed value leader
Sanofi
Comparable rows
7/7
Latest evidence
31 Mar 2026
13D/G
3/4/5
Lead comparable stake: 11%
13D/G row: 7. Cooperative Ua Lsp
Showing 1-6 of 7 holder rows.
Quick read
7. Cooperative Ua Lsp leads the comparable SEC ownership view at 11%.
7 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 7. Cooperative Ua Lsp's linked filing trail.
Comparable ownership
Top 5
7. Cooperative Ua Lsp
11%
FMR LLC
10%
Pontifax Management 4 G.P. (2015)...
6.8%
Sanofi
5.7%
Redmile Group, LLC
5.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 7. Cooperative Ua Lsp |
13D/G
LSP 7 Cooperatieve U.A.
|
11%
|
—
5,141,992 shares
|
$0 | 09 Feb 2026 |
| FMR LLC |
13D/G
|
10%
|
—
4,873,680 shares
|
$0 | 27 Feb 2026 |
| Pontifax Management 4 G.P. (2015) Ltd. |
13D/G
Pontifax VI G.P. L.P.
|
6.8%
|
—
3,305,846 shares
|
$0 | 31 Mar 2026 |
| Sanofi |
13D/G
|
5.7%
|
$28,415,410
2,783,096 shares
|
$0 | 31 Mar 2026 |
| Redmile Group, LLC |
13D/G
|
5.6%
|
—
2,735,926 shares
|
$0 | 31 Mar 2026 |
| Cormorant Asset Management, LP |
13D/G
|
5%
|
$25,171,203
2,465,348 shares
|
$0 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
32
Shares
23,354,227
Rows available
32
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
32
Q1 2026 holders
32
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend